{"id":"D0D2EC56-B65D-4A62-82A4-013AFFBE4208","title":"Application for a small exchange award to fund a 6-month sabbatical for Professor Wynick at the Neurology &amp; GI CEDD, GSK","abstractText":"Most pain killers never make it to market because of side effects and/or lack of effectiveness. In the 6 months I will spend at GSK, we will focus on the reasons for those failures and focus on (a) the most appropriate use of the latest cutting-edge in-vivo and in-vitro technologies to validate new pain targets and (b) new and improved models of neuropathic and spontaneous pain that are more relevant to the human diseases associated with chronic neuropathic pain eg multiple sclerosis and Type II diabetes mellitus.","grantUrl":"http://gtr.rcuk.ac.uk/projects?ref=G0700649","grantId":"G0700649","fundValue":"58569","fundStart":"2008-01-01","fundEnd":"2008-06-30","funder":"MRC","impactText":"","person":"David  Wynick","coPersons":[],"organisation":"University of Bristol","findingsText":"","dataset":"gtr"}